2Global Initiative for Asthma.Global Strategy for Asthma Diagnosis and Prevention.Global Initiative for Asthma(updated 2008)[EB/OL].[2010-11-04] http://www.ginasthma.org/download.asp?intld=343.
3Global Initiative for Asthma.Global Strategy for Asthma Diagnosis and Prevention.Global Initiative for Asthma(updated 2009)[EB/OL].[2010-11-04] http://www.ginasthma.com/download.asp?intld = 411.
5Sbirlea-Apiou G,Katz I,Caillibotte G,et al.Deposition mechanics of pharmaceulical particles in human airways[M] //Hickey AJ.Inhalation Aerosols.New York:Informa Healthcare USA,2007:1-30.
6Hess DR.Nebulizers:principles and performance[J].Respir Care,2000,45(6):609-622.
7Dolovich MB,Ahrens RC,Hess DR,et al.Device selection and outcomes of aerosol therapy:evidence-based guidelines:American College of Chest Physicians/American College of Asthma,Allergy,and Immunology[J].Chest,2005.127(1):335-371.
8Song IH,Buttgereit F.Non-genomic glucocorticoid effects to provide the basis for new drug developments[J].Mol Cell Endocrinol,2006,246(1-2):142-146.
9Nuhoglu Y,Atas E,Nuhoglu C,et al.Acute effect of nebulized budesonide in asthmatic children[J].J Investig Allergol Clin Immunol,2005,15(3):197-200.
10Desai D,Brightling C.Cough due to asthma,cough variant asthma and non-asthmatic eosinophilic bronchitis[J].Otolaryngol Clin North Am,2010,43(1):123-130.
